Retinal photocoagulation laser market seen reaching $7.69 billion by 2030

The global retinal photocoagulation laser market is projected to grow from $4.27 billion in 2025 to $7.69 billion by 2030, driven by rising retinal disease rates, aging populations and wider use of precision eye treatments. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Retinal photocoagulation lasers are used to treat retinal disorders that can cause irreversible vision loss. - Demand is rising as more patients need treatment for diabetic retinopathy, retinal vein occlusion, retinal tears and age-related macular degeneration. - The market’s growth signals continued investment in ophthalmic technology and outpatient eye care.

What happened: - The Business Research Company released its Retinal Photocoagulation Laser Global Market Report 2026 on Sept. 23, 2026. - The report estimates the market will reach $4.27 billion in 2025. - The report projects the market will rise to $4.82 billion in 2026. - The report forecasts the market will reach $7.69 billion by 2030. - The report puts the market’s 2025-2026 CAGR at 12.8% and the 2026-2030 CAGR at 12.4%.

The details: - Retinal photocoagulation lasers use focused laser energy to create controlled coagulation or seal abnormal retinal tissue and blood vessels. - The technology supports minimally invasive treatment and is intended to help preserve vision and limit further retinal damage. - Historical growth has been linked to higher rates of diabetic retinopathy and other retinal disorders. - Wider adoption of laser-based eye treatments, better ophthalmic infrastructure and advances in laser technology have also supported demand. - The report cites rising use of minimally invasive surgical procedures as another growth factor. - A July 2025 update from the UK Office for Health Improvement and Disparities reported 13,129 hospital admissions for rhegmatogenous retinal detachment surgeries in England in the financial year ending 2024. - That figure equaled 27.5 admissions per 100,000 people, up from 25.9 per 100,000 the prior year. - The report says North America held the largest regional share in 2025. - The report says Asia-Pacific is expected to be the fastest-growing region over the forecast period. - The analysis also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The biggest near-term driver is not just more disease, but more diagnosed disease that can be treated before vision loss becomes permanent. - AI and imaging tools are moving the market toward more precise, workflow-friendly treatment, which could expand use beyond traditional surgical settings. - Portable and less invasive devices point to a shift toward outpatient care, where lower treatment burden can improve adoption.

What's next: - The report expects AI-assisted retinal laser planning to improve targeting and clinical outcomes. - Image-guided photocoagulation tied to optical coherence tomography is expected to improve live retinal mapping. - Micropulse laser therapy is expected to gain traction because it may reduce tissue damage and speed recovery. - Multicolor laser systems are expected to broaden treatment accuracy across retinal diseases. - Improved healthcare access in developing regions and a growing elderly population are expected to support further demand.

The bottom line: - The retinal photocoagulation laser market is on a strong growth path, with clinical need, aging demographics and technology upgrades all reinforcing demand.